In cannabis plants, CBG is essentially the stem cell, or chemical precursor, of many other cannabinoids, and is present in virtually all cannabis plants in their early stages of flower. Clients travel from across the nation to sit down and pick the two brains behind the business: Eric Crawford and his co-founder and brother Seth Crawford. For the Crawford brothers, breeding a CBG-rich flower was only half the challenge. Strains high in CBG also could be beneficial for treating conditions such as inflammatory bowel disease, Crohn’s disease and cancer. CBG, the non-intoxicating cannabis compound whose full name is cannabigerol, has been garnering attention for its promising effects in the treatment of a wide variety of medical conditions.
It’s early on a mid-March Friday morning at the Oregon CBD headquarters, outside Corvallis, Oregon. The company’s co-founder, Eric Crawford, is breaking up a piece of intimidatingly frosty cannabis as I watch with apprehension.
“Don’t worry, it’s only hemp,” Crawford jokes as he packs the flower into the bowl of a glass pipe. “It has no measurable THC or CBD, but about 15 percent CBG and it really helps with staying focused.”
Fridays are usually filled with non-stop meetings at the industrial hemp seed firm, especially as the cannabis growing...
Read the full article @ Cannabis Now